ADRA2C CLIA Kit
Kurzübersicht für ADRA2C CLIA Kit (ABIN6209426)
Target
Alle ADRA2C CLIA Kits anzeigenReaktivität
Nachweismethode
Methodentyp
Detektionsbereich
Applikation
Proben
-
-
Untere Nachweisgrenze
- 0.625 ng/mL
-
Verwendungszweck
- Human Adrenergic Receptor alpha 2C (ADRa2C) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates and other biological fluids.
-
Analytische Methode
- Quantitative
-
Sensitivität
- < 0.237 ng/mL
-
-
-
-
Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
-
Plattentyp
- Pre-coated
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
-
Haltbarkeit
- 6 months
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Andere Bezeichnung
- Adrenergic Receptor alpha 2C (ADRa2C)
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target Alle ADRA2C CLIA Kits anzeigen
-